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Sleep dysregulation is a feature of dementia but it remains unclear whether sleep duration
prior to old age is associated with dementia incidence. Using data from 7959 participants of
the Whitehall II study, we examined the association between sleep duration and incidence of
dementia (521 diagnosed cases) using a 25-year follow-up. Here we report higher dementia
risk associated with a sleep duration of six hours or less at age 50 and 60, compared with a
normal (7 h) sleep duration, although this was imprecisely estimated for sleep duration at age
70 (hazard ratios (HR) 1.22 (95% confidence interval 1.01–1.48), 1.37 (1.10–1.72), and 1.24
(0.98–1.57), respectively). Persistent short sleep duration at age 50, 60, and 70 compared to
persistent normal sleep duration was also associated with a 30% increased dementia risk
independently of sociodemographic, behavioural, cardiometabolic, and mental health factors.
These findings suggest that short sleep duration in midlife is associated with an increased risk
of late-onset dementia.
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Changes in sleep patterns are common in persons withAlzheimer’s disease and other dementias1,2. These changesare believed to result from sleep–wake cycle dysregulation
due to pathophysiological processes in dementia, particularly
those affecting the hypothalamus and the brainstem3. Besides
sleep disturbance, there is growing interest in the association
between sleep duration and dementia1,2,4,5. Observational studies
show both short and long sleep duration to be associated with the
increased risk of cognitive decline and dementia1,4. Some studies
also report change in sleep duration in older adults to be asso-
ciated with the risk of dementia1,6–8.
Much of the evidence on the association between sleep dura-
tion and dementia comes from studies with a follow-up of <10
years. As most dementias are characterized by pathophysiological
changes over 20 years or more9,10, studies with a long follow-up
are needed to provide an insight into the association between
sleep duration and subsequent dementia. Among studies with a
follow-up of 10 years or longer7,11–15, many are based on parti-
cipants aged 65 years and older at baseline7,13–15, not allowing the
examination of the importance of sleep characteristics earlier in
the lifecourse. The number of dementia cases in the short and
long sleep groups in these studies is often small7,11–13, leading to
imprecise associations due to limited statistical power. Whether
the patterns of change in sleep duration leading up to old age is
associated with incidence of dementia is also unclear. In addition,
the role of mental health in the association of sleep duration with
dementia merits consideration16,17 as mental health disorders are
associated with both sleep duration18 and cognitive health19.
In this work, we use data from the Whitehall II cohort study
spanning 30 years to examine the association of sleep duration at
age 50, 60, and 70 with incident dementia, and to investigate
whether patterns of change in sleep duration over this period
were associated with dementia. In our analyses, we examine
whether mental disorders in midlife affects the association of
sleep duration with dementia. Given potential bias in self-
reported measures of sleep duration, we examine the association
between objectively assessed sleep duration and risk of dementia
in a sub-sample20 of the study. We find that short sleep duration
in midlife is associated with the higher risk of dementia later in
life, independently of sociodemographic, behavioural, cardiome-
tabolic, and mental health factors.
Results
Among the 10,308 persons recruited to the study in 1985–1988,
7959 had data on sleep duration and covariates when they were
50 years (mean age at clinical assessment= 50.6 years, standard
deviation (SD)= 2.6 years; flow chart in Fig. 1). Among these
participants, 521 developed dementia over a mean follow-up
period of 24.6 (SD= 7.0) years, the follow-up being 25.7 (SD=
5.1) years in dementia cases and 24.6 (SD= 7.1) years in non-
cases. Figure 1 also shows the construction of the analytic sample
for sleep duration at age 60 and 70. Cumulative hazards of
dementia as a function of sleep duration at age 50, 60, and 70 are
presented in Supplementary Fig. 1, and show that most cases of
dementia were diagnosed after the age of 70 years. Mean age at
diagnosis was 77.1 (SD= 5.6; range= 53.4–87.6) years.
Characteristics of study participants at age 50 are presented in
Table 1. Participants with sleep duration of 7 h per night, labelled
as normal sleep duration, were more likely to be men (69.1%
compared to 67.1% and 61.5% in short (≤6 h) and long (≥8 h)
sleepers, respectively), white (91.5% compared to 89.6 and
86.3%), married (77.9% compared to 72.9 and 75.6%), and to
have better cardiometabolic and mental health profile. Char-
acteristics of study participants at age 60 and 70 are shown in
Supplementary Table 1. As there was no evidence of systematic
sex differences (interaction of sex with sleep duration variables, all
P > 0.31), the analyses were conducted combining men and
women and adjusted for sex.
Association of sleep duration with dementia. Table 2 presents
the association of sleep duration at age 50, 60, and 70 with
incident dementia over a mean follow-up of 24.6 (SD= 7.0), 14.8
(SD= 5.9), and 7.5 (SD= 4.7) years, respectively. The lowest
dementia incidence per 1000 person-years was observed among
those who slept 7 h per night, irrespective of the age at which
sleep duration was measured. In analysis adjusted for socio-
demographic factors, short sleep duration was associated with the
higher risk of incident dementia at all ages (all P < 0.02). Further
adjustment for health behaviours and cardiometabolic and
mental health factors attenuated associations, but there remained
an association for short sleep at 50 (hazard ratio (HR)= 1.22,
95% confidence interval (CI)= 1.01–1.48) and 60 years (HR=
1.37, 95% CI= 1.10–1.72). There was no clear evidence of an
association between long sleep duration and incident dementia.
A total of 6875 participants were alive, free of dementia at age
70, and had at least two out of the three measures of sleep
duration at age 50, 60, and 70. Among them, 426 had incident
dementia over a mean follow-up period of 7.4 (SD= 4.7) years.
Using these data on sleep duration, six trajectories were identified
and labelled as: persistent short sleep, persistent normal sleep,
persistent long sleep, change from short to normal sleep, change
from normal to long sleep, and change from normal to short sleep
(Table 3). Persistent short sleep duration was associated with an
increased risk of dementia (HR= 1.30, 95% CI= 1.00–1.69)
compared to those with persistent normal sleep duration
(Table 4). There was also a signal of higher risk in participants
with persistent long sleep and those who reported short sleep at
least once, but the associations did not reach statistical
significance. Analyses restricted to participants without a history
of mental illness before age 65 years (Table 5) showed
associations of sleep duration and change in sleep duration with
subsequent dementia to be similar to that in the main analyses.
Data on accelerometer-assessed sleep duration collected in
2012–2013 were available on 4267 participants. Data were
excluded due to absence of sleep log (n= 140), technical problem
(n= 175), significant non-wear (n= 23), and missing covariates
(n= 41) leading to a total of 3888 participants included in the
analysis, among whom 111 developed dementia over a mean 6.4-
year follow-up period. Characteristics of this analytical sample are
presented in Supplementary Table 2. The Pearson’s correlation
between questionnaire and accelerometer-assessed measures of
sleep duration in 2012–2013 was 0.41 (P < 0.001). The association
between accelerometer-assessed sleep duration, modelled as a
continuous variable, and dementia is shown in Fig. 2. Compared
to 7 h of sleep, sleep duration <6 h per night was associated with
the higher risk of dementia, whereas sleep duration >8 h per night
was not associated with risk of dementia (Fig. 2a, Source data),
the estimates for long sleep duration were further attenuated
when missing data were taken into account (Fig. 2b, Source data).
The analysis of these data using tertiles, with the second tertile as
the reference (6 h 14 min–7 h per night), showed sleep duration
in the first tertile (1 h 16 min–6 h 13 min) to be associated with an
increased risk of dementia (HR= 1.63, 95% CI= 1.04–2.57),
while there was no association with dementia in the highest tertile
(7 h 1 min–10 h 6 min), Table 6.
Sensitivity analysis. Participants who could not be included in the
analyses due to missing data (N= 1987) were older at recruitment
to the study in 1985–1988 (45.4 vs 41.5 years, P < 0.001), and more
likely to develop dementia over the follow-up (6.6% vs 4.0%, P <
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0.001), although no differences were observed in relation to sex (P
= 0.81) or sleep duration (P= 0.65) categories. Analyses using
inverse-probability weighting to account for missing data led to
results that were consistent with those in the main analysis, as well
as the accelerometer sub-study (Table 7).
Adding apolipoprotein E (APOE) ε4 as a covariate in the
analysis did not alter observed associations between sleep
duration at age 50, 60, and 70 and risk of dementia
(Supplementary Table 3). Use of dementia without history of
cardiovascular disease as a proxy for Alzheimer’s disease type of
dementia (N cases= 404, 77.5% of the 521 all cause dementia
cases) yielded results similar to those in the main analysis
although the estimates were imprecise due to smaller numbers in
analysis (Supplementary Table 4).
Discussion
This longitudinal study of nearly 8000 participants with repeat
data on sleep duration and a long follow-up for dementia suggests
short sleep duration in midlife to be associated with the increased
risk of incident dementia. This finding was confirmed in analysis
using sleep duration measured by an accelerometer. Measurement
Fig. 1 Flow chart for population selection. This figure represents the sample selection for the analysis of sleep duration at age 50, 60, and 70, as well as for
the analysis of sleep trajectories.
Table 1 Characteristics of the study population at age 50.
Sleep duration at age 50 Dementia status at end of follow-up
Short: ≤6 h Normal: 7 h Long: ≥8 h P No dementia Dementia P
N 3149 3624 1186 7438 521
Women 1035 (32.9) 1118 (30.9) 456 (38.5) <0.001 2390 (32.1) 219 (42.0) <0.001
Ethnicity, Nmon-white 326 (10.4) 309 (8.5) 163 (13.7) <0.001 719 (9.7) 79 (15.2) <0.001
Less than secondary school diploma 1522 (48.3) 1722 (47.5) 575 (48.5) 0.75 3509 (47.2) 310 (59.5) <0.001
Married/cohabiting 2296 (72.9) 2823 (77.9) 897 (75.6) <0.001 5647 (75.9) 369 (70.8) 0.009
Moderate alcohol drinking (1–14 units
per week)
1695 (53.8) 2042 (56.4) 618 (52.1) 0.02 4082 (54.9) 273 (52.4) 0.27
Current smokers 519 (16.5) 552 (15.2) 168 (14.2) 0.13 1138 (15.3) 101 (19.4) 0.013
Moderate-to-vigorous physical activity
(h), M (SD)
3.3 (3.9) 3.4 (3.5) 3.2 (3.6) 0.14 3.3 (3.7) 3.3 (3.7) 0.78
Daily fruit and vegetable consumption 1953 (62.0) 2341 (64.6) 777 (65.5) 0.03 4774 (64.2) 297 (57.0) 0.001
BMI≥ 30 kg/m² 414 (13.2) 355 (9.8) 120 (10.1) <0.001 823 (11.1) 66 (12.7) 0.26
Diabetes 97 (3.1) 80 (2.2) 22 (1.9) 0.02 182 (2.5) 17 (3.3) 0.25
Hypertension 779 (24.7) 783 (21.6) 288 (24.3) 0.006 1700 (22.9) 150 (28.8) 0.002
Cardiovascular disease 105 (3.3) 91 (2.5) 28 (2.4) 0.07 214 (2.9) 10 (1.9) 0.20
GHQ depression 577 (18.3) 439 (12.1) 143 (12.1) <0.001 1070 (14.4) 89 (17.1) 0.09
CNS medications 169 (5.4) 130 (3.6) 59 (5.0) 0.001 322 (4.3) 36 (6.9) 0.006
Mental disorders before age 65 259 (8.2) 231 (6.4) 93 (7.8) 0.01 541 (7.3) 42 (8.1) 0.51
Values are No. (%) unless stated otherwise. Two-sided Ps for heterogeneity were estimated using χ² test for categorical variables, and ANOVA for continuous variables by sleep duration groups and
Student’s t test by dementia groups for continuous variables.
BMI body mass index, CNS central nervous system, GHQ general health questionnaire, M mean, SD standard deviation.
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of sleep duration at age 50, 60, and 70 years along with change in
sleep duration over this period provides consistent results for
increased risk of dementia in those with short sleep. A further key
finding is that the association between short sleep duration and
dementia is not attributable to mental health.
Two recent meta-analyses suggest a U-shaped association
between sleep duration and incident dementia, with lower risk in
people sleeping 7 h per night, and greater risk among those with
shorter sleep and also among those with longer sleep duration4,5.
The studies included in these meta-analyses had a follow-up
duration ranging from 3 to 23 years, but most studies had a
follow-up of <10 years4,5. Dementia at older ages is characterized
by a long preclinical period9,20, and studies with a follow-up of 10
years are likely to be subject to reverse causation bias, whereby
the putative risk factor is affected by the disease process in
dementia.
Some studies11–15 are noteworthy because of their long follow-
up. In the Kuopio Ischaemic Heart Disease study on 2386 men
aged 42–62 years at assessment of sleep duration, there was no
association between sleep duration (categorized as ≤6.5, 7–8, and
≥8.5 h) and incidence of dementia over a 22-year mean follow-
up12. On the other hand, a U-shaped association between sleep
duration and dementia was observed in three studies, where the
mean age at sleep duration assessment varied between 50 and 73
years, and follow-up between 15 and 23 years11,13,14. In the Fra-
mingham Heart study, long (N= 96) but not short (N= 209)
sleep duration at mean age 72 years was associated with dementia
over a 10-year follow-up7. In a large-scale Swedish cohort of
28,775 individuals aged 65 years and older, the association
between long sleep duration and dementia over a 13-year follow-
up was completely attenuated after cases occurring in the first 5
years of follow-up were excluded from the analysis, highlighting
the role of reverse causation bias15. All these studies use a wide age
range at baseline for assessment of sleep duration and it is likely
that the older participants, those most likely to be diagnosed with
dementia over the follow-up, are already subject to preclinical
changes that characterize dementia. This long preclinical period of
dementia makes it less amenable to research using gold-standard
approaches, such as randomized controlled trials. Observation
studies are not ideally suited for causal inference, but careful
analysis that considers time between exposure and outcome can be
helpful in determining changes over time in the nature of the
association between the exposure of interest and dementia.
In the present study, we used an innovative approach con-
sisting of extracting data on sleep duration at age 50, 60, and 70 in
order to remove the uncertainty in estimations caused by inclu-
sion of a wide age range at the start of the follow-up. The pattern
of associations in relation to short sleep duration and dementia
was similar at age 50, 60, and 70, even though sleep duration at
age 70 was not associated with dementia after adjustment for
health-related factors. Analysis of trajectories of sleep duration
using data from sleep duration at age 50, 60, and 70 showed
persistent short sleep duration to be associated with an increased
risk of dementia. Depression and mood disorders in general are
related to changes in sleep and thought to play an important part
in the association of sleep duration with dementia8. In the present
study, adjustment for depressive symptoms and central nervous
system (CNS) drugs, as well as analysis undertaken among those
without a history of mental disorders did not show mental health
to explain the association. Our results are consistent with a recent
Mendelian randomization study, where sleep-related phenotypes
were found not to be related to mental disorder17. Results in our
study were robust to adjustments for a wide range of covariates,
including cardiovascular disease16, suggesting a consistent asso-
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There is evidence of a bidirectional association between sleep
dysfunction and pathophysiological changes in dementia21,22,
highlighting the need for a longer time frame in studies. The
results for short sleep duration seen in our study is likely to
involve several processes1, including neuroinflammation23,
atherosclerosis24, alpha-synucleinopathies (dementia with Lewy
bodies and Parkinson disease dementia)25, and impaired
amyloid-β clearance26, possibly due to impaired glymphatic
function27. Experimental studies support a detrimental effect of
sleep deprivation on cognitive performance28 and β-amyloid (Aβ)
clearance29–31. Amyloid plaque build-up contributes to poor
sleep in older adults through its direct impact on sleep–wake
regulator brain regions21,22. There is also some evidence of an
association of Aβ accumulation with disruption of the circadian
rhythm and sleep pattern in cognitively normal adults32. Much of
the research on mechanisms focusses on sleep disturbance rather
than sleep duration, particularly in relation to the years leading
up to dementia diagnosis. The mechanisms linking short sleep
duration to dementia may be similar1,33, but a better under-
standing of how sleep features (duration, disturbance, sleep
apnoea, and sleep–wake regulation) over the adult lifecourse
shape risk of dementia at older ages is required to identify win-
dows of opportunity for therapeutic interventions to reduce the
risk or delay the progression of dementia and its subtypes.
In contrast to some previous studies7,11,14,15, we did not find
strong evidence to support the hypothesis that long sleep duration
is associated with dementia. As in most previous studies7,11–13,
the number of long sleepers in our study was small and did not
allow a robust estimation of the association with long sleep
duration. Two large-scale studies based on individuals with a
mean age of 72 years, followed for 12 and 14 years reported sleep
duration >9 h to be associated with the increased risk of
dementia14,15. Given the age of these individuals at the start of
follow-up, more data on long sleepers in midlife and old age are
needed to draw conclusions on the importance of long sleep
duration for dementia.
Strengths of the present study include repeat measures of sleep
duration and a long follow-up for dementia allowing the exam-
ination of age at assessment of sleep duration, and change therein
to provide insight into the nature of the association between sleep
duration and dementia. Use of an objective measure of sleep
duration confirmed the main findings that were based on self-
reported sleep duration. We also undertook sensitivity analysis
using inverse-probability weighting to take missing data into
account, and results from these analyses were in accordance with
the main findings.
Assessment of dementia cases via electronic health records is not
ideal but has some advantages. It allows ascertainment of dementia
status in all participants and not only those who agree to continue
to participate in multiple waves of data collection over time.
However, this method may misclassify some dementia cases, par-
ticularly milder cases of dementia34, although the misclassification
Table 3 Description of sleep duration at age 50, 60, and 70
by groups of trajectories of sleep duration.
N Sleep duration, mean (standard
deviation) (h)
Age 50 Age 60 Age 70
Persistent short 1358 6.0 (0.0) 6.0 (0.0) 6.0 (0.0)
Persistent normal 2520 7.2 (0.4) 7.0 (0.5) 6.8 (0.5)
Persistent long 461 8.0 (0.0) 8.0 (0.0) 7.8 (0.4)
Change from short to normal 1086 6.0 (0.0) 6.7 (0.6) 6.9 (0.6)
Change from normal to long 946 6.9 (0.5) 7.5 (0.6) 8.0 (0.0)
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is likely to be independent from measures of sleep duration. Data
on dementia type were incomplete in the records and our use of a
proxy measure of Alzheimer’s disease dementia may not be precise
despite the proportion of cases being in accordance with that in the
general population10. The observational nature of the study cannot
preclude residual confounding despite our adjustment for a large
set of covariates. A further limitation is that Whitehall II study
participants were all in employment at recruitment and are
healthier than the general population, both in terms of risk factor
profiles and incidence of disease. However, the association between
risk factors and disease of interest is not necessarily affected35. A
previous study showed that the association between cardiovascular
risk factors and risk of CVD in the Whitehall II study was similar
to that in general population studies36.
There is a widely acknowledged association between sleep and
cognitive function1, primarily due to the role of sleep in learning
Table 5 Association between sleep duration and dementia: analysis restricted to participants without mental disorders before
65 years.
Total population Among those free of mental disorders before 65 years
N cases/N total HRa (95% CI) P valueb N cases/N total HRa (95% CI) P valueb
Sleep duration at age 50
Short: ≤6 h 211/3149 1.22 (1.01–1.48) 0.04 195/2890 1.25 (1.03–1.53) 0.03
Normal: 7 h 219/3624 1 (ref.) 202/3393 1 (ref.)
Long: ≥8 h 91/1186 1.25 (0.98–1.60) 0.07 82/1093 1.23 (0.95–1.60) 0.11
Sleep duration at age 60
Short: ≤6 h 192/2759 1.37 (1.10–1.72) 0.005 170/2520 1.28 (1.02–1.62) 0.04
Normal: 7 h 142/2988 1 (ref.) 134/2779 1 (ref.)
Long: ≥8 h 75/1417 1.15 (0.87–1.52) 0.34 72/1288 1.20 (0.90–1.60) 0.22
Sleep duration at age 70
Short: ≤6 h 171/2429 1.24 (0.98–1.57) 0.10 159/2237 1.28 (1.00–1.63) 0.049
Normal: 7 h 131/2578 1 (ref.) 122/2418 1 (ref.)
Long: ≥8 h 90/1509 1.15 (0.88–1.51) 0.60 85/1391 1.22 (0.93–1.62) 0.16
Trajectories of sleep duration between age 50 and 70
Persistent short 103/1358 1.30 (1.00–1.69) 0.048 94/1253 1.29 (0.98–1.69) 0.06
Persistent normal 141/2520 1 (ref.) 132/2353 1 (ref.)
Persistent long 35/461 1.28 (0.88–1.85) 0.20 32/430 1.26 (0.85–1.85) 0.25
Change from short to normal 61/1086 1.20 (0.89–1.63) 0.23 59/1006 1.28 (0.94–1.74) 0.12
Change from normal to long 47/946 1.02 (0.73–1.42) 0.90 45/870 1.11 (0.79–1.56) 0.55
Change from normal to short 39/504 1.13 (0.79–1.62) 0.50 36/462 1.16 (0.80–1.56) 0.43
CI confidence intervals, HR hazard ratio, SD standard deviation.
aHR estimated from a Cox regression adjusted for age (timescale), sex, ethnicity, education, and marital status, alcohol consumption, physical activity, smoking status, and fruit and vegetable
consumption, BMI, hypertension, diabetes, cardiovascular disease, GHQ depression, and CNS medications.
bTwo-sided P value for HR in comparison with the reference (ref.) category, without adjustment for multiple comparisons.
Fig. 2 Association of objectively assessed sleep duration (2012–2013, N cases/N total= 111/3888) with incident dementia over a mean follow-up of
6.4 (SD= 1.0) years: accelerometer sub-study. a The hazard ratio for dementia (black plain line) with the corresponding 95% confidence interval (black
dotted line) as a function of sleep duration from a Cox regression adjusted for age (timescale), sex, ethnicity, education, marital status, alcohol
consumption, physical activity, smoking status, fruit and vegetable consumption, BMI, hypertension, diabetes, cardiovascular disease, GHQ depression, and
CNS medications (Source data). b The hazard ratio for dementia (black plain line) with the corresponding 95% confidence interval (black dotted line) as a
function of sleep duration from a Cox regression using inverse-probability weighting to account for missing data and adjusted for age (timescale), sex,
ethnicity, education, marital status, alcohol consumption, physical activity, smoking status, fruit and vegetable consumption, BMI, hypertension, diabetes,
cardiovascular disease, GHQ depression, and CNS medications (Source data).
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and memory, synaptic plasticity, and waste clearance from the
brain1,37,38. Whether sleep parameters also affect late-life
dementia remains the subject of debate. While incipient demen-
tia is known to affect sleep–wake cycles1,2,7, the extent to which
sleep duration over the adult lifecourse is associated with late-
onset dementia is unclear because most studies have not explicitly
considered age at assessment of sleep duration or the length of
follow-up. Our approach pays attention to both these aspects
along with inclusion of a wide array of covariates to show that
short sleep duration in midlife is associated with an increased risk
of dementia. Public health messages to encourage good sleep
hygiene39 may be particularly important for people at a higher
risk of dementia.
Methods
Study population. The Whitehall II study is a cohort study that was established
among 10,308 British civil servants (33.1% women, age range 35–55) in 1985–1988
(ref. 40). Since baseline, follow-up clinical data collection waves have taken place
every 4–5 years with each wave lasting ~2 years, with the last wave conducted in
2015–2016. In addition to clinical examinations in the study, data over the follow-
up are obtained via linkage to electronic health records of the UK National Health
Service (NHS) for participants recruited to the study. The NHS provides most of
the health care in the country, including in- and out-patient care, and record
linkage is undertaken using a unique NHS identifier held by all UK residents. Data
from linked records were updated on an annual basis, until 31st March 2019.
Written, informed consent from participants was obtained at each contact.
Research ethics approvals were renewed at each wave; the most recent approval was
obtained from the University College London Hospital Committee on the Ethics of
Human Research (reference number 85/0938).
Measures
Sleep duration. Sleep duration was assessed by questionnaire in 1985–1988,
1997–1999, 2002–2004, 2007–2009, 2012–2013, and 2015–2016 using the question
‘how many hours of sleep do you have on an average weeknight?’. Response
categories were 5 h or less, 6, 7, 8, and 9 h or more. We extracted sleep duration at
age 50, 60, and 70 for each participant across the data waves, allowing a ±5-year
margin for each age category. In order to allow sufficient number of dementia cases
in each sleep category, we pooled categories of sleep duration as follows: short (≤6 h
per night), normal (7 h per night), and long (≥8 h per night)41.
Trajectories of change in sleep duration between age 50 and 70 were defined
using group-based trajectory modelling using the traj-command in Stata42. Groups
were chosen according to model fit statistics (Bayesian Information Criterion
values and average posterior probabilities) and meaningful interpretation43. The
sleep duration categories in the construction of trajectories were the same as in the
main analyses, and were based on participants who were alive and free of dementia
at age 70 with at least two out of three measures of sleep duration at age 50, 60,
and 70.
The accelerometer substudy was undertaken in 2012–2013 (ref. 44) on study
participants who either attended the central London research clinic or were seen at
home in those living in the South-Eastern regions of England. These participants
were asked to wear a wrist-worn accelerometer, the GENEActiv (Activinsights Ltd,
Kimbolton, UK), during nine consecutive days over 24 h. Sleep duration was
estimated using a validated algorithm guided by a sleep log and implemented in R
(version 3.6.3) package GGIR version 2.0-1 (ref. 45); data from the first and last
nights were removed leading to data over 7 nights45. Usual daily sleep duration was
estimated as the mean of sleep duration over the 7 nights and for those with
<7 days of measurement, weighted average of sleep duration was calculated
according to week days and weekend days46. Accelerometer-assessed sleep duration
was categorized into tertiles rather than categories used for self-reported sleep as
only 167 (six dementia cases) participants had accelerometer-assessed sleep
duration of 8 h or more. Study participants were between 60 and 83 years in this
sub-study, a one-off addition to the main data collection. Therefore, age-specific
analysis as in the self-reported measure of sleep duration was not possible with the
accelerometer data.
Dementia. Dementia cases were ascertained by linkage to three national registers
(the national hospital episode statistics (HES) database, the Mental Health Services
Data Set, and the mortality register) up to the 31st of March 2019 using the unique
National Health Service (NHS) identification number. Dementia cases were
identified based on ICD-10 codes F00-F03, F05.1, G30, and G31. The NHS pro-
vides most of the health care, including out- and in-patient care. The sensitivity
and specificity of dementia in the NHS HES data is 78.0 and 92.0% (ref. 34). The
sensitivity in our study is likely to be higher as we also used data from the Mental
Health Services Data Set, a national database that contains information on
dementia for persons in contact with mental health services in hospitals, out-
patient clinics, and the community47. The first record of dementia diagnosis in any
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Covariates. Sociodemographic variables included age, sex, ethnicity (white and non-
white), education (lower primary school or less, lower secondary school, higher
secondary school diploma, and university), and marital status (married or coha-
biting, and other). Health behaviours included cigarette smoking status (never
smoker, ex-smoker, and current smoker), alcohol consumption in the previous week
(no alcohol in the previous week, 1–14 units per week, and >14 units per week),
time spent in moderate and vigorous physical activity, and frequency of fruits and
vegetables consumption (less than daily, once a day, and twice or more a day).
Health-related variables included measures of cardiometabolic risk factors and
mental health. Cardiometabolic factors were hypertension (systolic ≥140 or
diastolic ≥90 mmHg or use of antihypertensive medication), diabetes mellitus
(determined by fasting glucose ≥7.0 mmol/L, reported doctor-diagnosed diabetes,
use of diabetes medication, or hospital record), body mass index (BMI, categorized
as <20, 20–24.9, 25–29.9, and ≥30 kg/m²) based on height and weight assessment at
the clinical examination using standard clinical protocols, and cardiovascular
disease (including coronary heart disease and stroke identified using linkage to
national hospital records). Mental health factors included current depressive
symptomatology defined by the four-item depression subscale of the General
Health Questionnaire48, and self-reported use of CNS medication (anti-depressant,
antipsychotic, hypnotic, anxiolytic, or Parkinson medications).
History of mental disorders before age 65 was assessed based on self-reported use
of anti-depressants or linkage to national hospital records and mental health registry
based on ICD codes F06, F07, F09, F20–48, and F60–69 (excluding F65 and F66).
Statistical analysis. Four sets of analyses were undertaken, described below (Fig. 1
for flow chart). All analyses were performed using Cox regression with age as the
timescale to model the associations with incident dementia. Participants were
included into the analysis if they had data on sleep duration and covariates assessed
at the age of interest allowing a ±5-year margin and were free of dementia at this
date. Data were censored at date of record of dementia, death, or March 31st 2019,
whichever came first. The proportional hazard assumption was verified using
Schoenfeld residuals. Analyses were first adjusted for sociodemographic factors,
then additionally for health behaviours, and finally for health-related factors.
We first examined the association between sleep duration at age 50, 60, and 70,
in separate models, and incident dementia. For these analyses, age of entry was the
age at clinical assessment closest to the age of interest from which the sleep
duration measure and covariates were drawn.
We examined the association of trajectories of sleep duration, to reflect changes
between the age of 50 and 70, with incident dementia with age of entry and
covariates drawn from when participants were 70 years.
In order to assess the role of mental disorders in the association of sleep
duration with dementia, we repeated the previous analyses, excluding participants
with mental disorders before the age of 65. Mental disorders diagnosed after age 65
were not excluded as they could be features of the preclinical period of dementia49.
The final analyses examined the association between objectively assessed sleep
duration and incident dementia. Participants were followed from the age at
accelerometer assessment, and covariates were drawn from the same wave of data
collection. To examine the shape of the association between accelerometer-assessed
sleep duration, measured in rich detail, and incidence of dementia we used
restricted cubic spline regressions with Harrell knots50, Stata command xblc51, with
7 h as the reference. Then, in further analyses tertiles of accelerometer-assessed
sleep duration were used.
We undertook a series of additional/sensitivity analysis. One, we repeated the
main analyses using inverse-probability weighting to account for missing data52.
This involved first calculating the probability of being included in the analytical
sample using logistic regression that included demographic, socioeconomic,
behavioural factors, as well as sleep duration at recruitment, morbidities including
dementia and mortality over follow-up, and stepwise-selected interactions between
covariates. The inverse of these probabilities were used as weights in Cox
regression. Two, in a sub-sample of participants with data on APOE genotype, we
repeated the main analyses with APOE ε4 (1 or 2, vs 0) as a covariate in the
analysis. Three, in order to examine whether observed results apply to dementia
due Alzheimer’s disease, we repeated the analyses using a proxy definition of this
outcome. This consisted of defining Alzheimer’s disease dementia as dementia
cases free of cardiovascular disease (stroke or myocardial infarction)53 over the
follow-up. Analyses 2 and 3 were exploratory and due to smaller numbers in
analysis the direction of results rather than statistical significance should be given
more importance. All analyses were performed using STATA version 16.1
(StataCorp). A two-sided P value ≤ 0.05 was considered statistically significant.
STROBE statement is available in the online Supplement.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Data used for analyses comprise data assessed at study clinical examinations in
1985–1988, 1997–1999, 2002–2004, 2007–2009, 2012–2013, and 2015–2016. In addition
to clinical examinations in the study, data over the follow-up were obtained via linkage to
electronic health records of the UK National Health services for participants recruited to
Table 7 Sensitivity analysis: use of inverse-probability weighting (IPW) to account for missing data.
N cases/N total Main analysis Analysis using IPW to account for
missing data
HRa (95% CI) P valueb HRa (95% CI) P valueb
Sleep duration at age 50
Short: ≤6 h 211/3149 1.22 (1.01–1.48) 0.04 1.21 (0.99–1.48) 0.06
Normal: 7 h 219/3624 1 (ref.) 1 (ref.)
Long: ≥8 h 91/1186 1.25 (0.98–1.60) 0.07 1.28 (0.99–1.66) 0.06
Sleep duration at age 60
Short: ≤6 h 192/2759 1.37 (1.10–1.72) 0.005 1.31 (1.03–1.66) 0.03
Normal: 7 h 142/2988 1 (ref.) 1 (ref.)
Long: ≥8 h 75/1417 1.15 (0.87–1.52) 0.34 1.25 (0.93–1.66) 0.14
Sleep duration at age 70
Short: ≤6 h 171/2429 1.24 (0.98–1.57) 0.10 1.14 (0.88–1.46) 0.32
Normal: 7 h 131/2578 1 (ref.) 1 (ref.)
Long: ≥8 h 90/1509 1.15 (0.88–1.51) 0.60 1.14 (0.85–1.52) 0.39
Trajectories of sleep duration between age 50 and 70
Persistent short 103/1358 1.30 (1.00–1.69) 0.048 1.24 (0.94–1.64) 0.13
Persistent normal 141/2520 1 (ref.) 1 (ref.)
Persistent long 35/461 1.28 (0.88–1.85) 0.20 1.33 (0.90–1.96) 0.15
Change from short to normal 61/1086 1.20 (0.89–1.63) 0.23 1.21 (0.88–1.69) 0.24
Change from normal to long 47/946 1.02 (0.73–1.42) 0.90 1.02 (0.71–1.45) 0.93
Change from normal to short 39/504 1.13 (0.79–1.62) 0.50 1.12 (0.75–1.68) 0.57
Accelerometer-assessed sleep duration
Tertile 1: 1 h 16 min–6 h 13 min 53/1296 1.63 (1.04–2.57) 0.03 1.63 (1.03–2.59) 0.04
Tertile 2: 6 h 14min–7 h 0min 31/1296 1 (ref.) 1 (ref.)
Tertile 3: 7 h 1 min–10 h 6min 27/1296 0.78 (0.46–1.32) 0.36 0.82 (0.47–1.41) 0.82
CI confidence intervals, HR hazard ratio, IPW inverse-probability weighting, h hour, min minute.
aHR estimated from a Cox regression adjusted for age (timescale), sex, ethnicity, education, and marital status, alcohol consumption, physical activity, smoking status, and fruit and vegetable
consumption, BMI, hypertension, diabetes, cardiovascular disease, GHQ depression, and CNS medications.
bTwo-sided for HR in comparison with the reference (ref.) category, without adjustment for multiple comparisons.
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the study, including hospital episode statistics databased, Mental Health Services Data
Set, and the mortality register. Data from linked records were updated on an annual
basis, until 31st March 2019. Following NHS Digital guidelines, these data are available
for sharing with the scientific community either through the study specific data sharing
https://www.ucl.ac.uk/epidemiology-health-care/research/epidemiology-and-public-
health/research/whitehall-ii/data-sharing or using the Dementias platform UK https://
www.dementiasplatform.uk/for-researchers/data-portal-getting-started-with-cohort-
data. Source data are provided with this paper.
Code availability
Code for statistical analysis is provided in https://doi.org/10.5281/zenodo.4572438.
Received: 21 October 2020; Accepted: 9 March 2021;
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